Search for: "WYETH PHARMACEUTICALS INC "
Results 481 - 500
of 515
Sorted by Relevance
|
Sort by Date
30 Aug 2016, 2:33 pm
Wyeth, Inc., Dr. [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
31 Jan 2023, 6:36 pm
Ortho Pharmaceutical Corp., 788 F. 2d 741, 744–745 (11th Cir. 1986). [read post]
15 Mar 2010, 2:09 pm
BIC USA, Inc., 136 F.Supp.2d 196, 207-208 (S.D.N.Y. 2000) (Consumer Product Safety Commission) (“The CPSC regulations establish general, rudimentary and minimal requirements. [read post]
18 Dec 2008, 10:36 pm
Sandoz Pharmaceuticals Corp., 2002 WL 32153352, at *1 (S.D. [read post]
27 Jun 2008, 10:04 am
: (The Invent Blog), Impressive work on history of ‘Happy Birthday’ and copyright protection: (Innovationpartners), Gender and copyright: (Patry Copyright Blog) Events 1 July: US PLI: ‘Prior art & obviousness 2008: The PTO and CAFC perspective on patent law sections 102 & 103’ - New York: (Patent Docs), 1-2 July – C5 conference on intellectual asset management for high-tech industries – Paris: (c5-online.com), 2… [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its… [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation amendments to dodge real story:… [read post]
3 Apr 2009, 5:10 am
Department of Justice, Burroughs Corp., Colgate-Palmolive Co. and Pitney Bowes Inc. [read post]
5 Jul 2008, 11:05 am
, (Daily Dose of IP), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South Africa): (Afro-IP), 15-16 September: US ACI 10th advanced forum on biotech… [read post]
16 Dec 2010, 1:54 pm
We would all go down together!! [read post]
31 May 2007, 4:31 am
Ortho-McNeil Pharmaceutical, Inc., 463 F. [read post]
6 May 2010, 4:12 pm
Novartis Pharmaceuticals Corp., 564 F. [read post]
20 Dec 2007, 7:57 am
Dingell stating that "[s]ince July, bipartisan meetings have been held frequently between House Energy and Commerce Committee and the Senate Committee on Health, Education, Labor, and Pensions to reconcile the differences between these two bills. [read post]
3 Apr 2009, 3:49 am
WellPoint, Inc. [read post]
22 Nov 2008, 2:52 pm
Wal-Mart Stores, Inc., No. 08-10761 (11th Cir. [read post]
27 Sep 2007, 11:38 am
Fujisawa Pharmaceutical Co., 464 F. [read post]
2 Dec 2015, 12:38 pm
Metabolife Int’l, Inc., 401 F.3d 1233, 1241 (11th Cir. 2005) (reversing admission of expert witness’s testimony when the witness conceded a dose-response, but failed to address the dose of the medication needed to cause the claimed harm). [read post]
10 Apr 2014, 11:58 am
Janssen Pharmaceuticals, Inc., 2014 WL 1335511 (Pa. [read post]
12 Sep 2013, 7:37 am
Ct. 2567 (2011), and Mutual Pharmaceutical Co. v. [read post]
